Want to see IMUX full AI Analyst Report?

Immunic (IMUX) Ownership - Who Owns Immunic?

Q: What percentage of Immunic, Inc. (IMUX) stock is held by retail investors?

According to the latest TipRanks data, approximately 77.77% of Immunic, Inc. (IMUX) stock is held by retail investors.

Q: Who owns the most shares of Immunic, Inc. (IMUX)?

Fidelity Concord Street Trust owns the most shares of Immunic, Inc. (IMUX).

Q: What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.

2,239 Followers

Immunic (IMUX) Ownership Overview

9.28% Insiders

8.49% Mutual Funds

<0.01% Other Institutional Investors

4.46% ETFs

77.77% Public Companies and Individual Investors

The ownership structure of Immunic (IMUX) stock is a mix of institutional, retail, and individual investors. Approximately 12.95% of the company’s stock is owned by Institutional Investors, 9.28% is owned by Insiders, and 77.77% is owned by Public Companies and Individual Investors.

The ownership structure of Immunic (IMUX) stock is a mix of institutional, retail, and individual investors. Approximately 8.49% of the company’s stock is owned by Institutional Investors, 9.28% is owned by Insiders, and 4.46% is owned by Public Companies and Individual Investors.

Recent Insider Trading Activity

Date	Name	Activity	Value
Jun 16, 2025	Duane Nash	xxxxxxxxxxxxx	$16600

Show More Insider Trading Activity >

Recent Hedge Fund Trading Activity

Date	Firm	Activity	Value
Dec 31, 2023	Graham Capital Management, L.p.	xxxxxxxxxxxxx	$36963
Dec 31, 2023	Woodline Partners Lp	xxxxxxxxxxxxx	$1073537

Show More Hedge Fund Trading Activity >

Top Shareholders

Holder	# of Shares	Type	% Holding	Value
	1,142,358	Institution	8.39%	16,724,121
Michael Rockefeller	967,152	Institution	7.10%	14,159,105
	502,081	Institution	3.69%	7,350,466
	391,877	Insider	2.88%	5,737,079
	297,986	Insider	2.19%	4,362,515
	230,375	Insider	1.69%	3,372,690
	200,000	Insider	1.47%	2,928,000
	95,510	Insider	0.70%	1,398,266
	46,243	Institution	0.34%	676,998
	36,032	Insider	0.26%	527,508

Top Mutual Fund Holders

# of Shares	Type	% Holding	Value
1,142,358	Institution	8.39%	16,724,121
8,500	Institution	0.06%	124,440
3,975	Institution	0.03%	58,194
1,878	Institution	0.01%	27,494

Top ETF Holders

Holder	# of Shares	Type	% Holding	Value
Vanguard Total Stock Market ETF	366,388	Institution	2.69%	5,481,164
Vanguard Extended Market ETF	135,693	Institution	1.00%	2,029,967
iShares Micro-Cap ETF	46,243	Institution	0.34%	683,009
Simplify Propel Opportunities ETF	30,725	Institution	0.23%	449,814
ALPS Medical Breakthroughs ETF	14,877	Institution	0.11%	217,799
Invesco NASDAQ Future Gen 200 ETF	7,329	Institution	0.05%	108,249
Avantis U.S Small Cap Equity ETF	6,203	Institution	0.05%	91,618

FAQ

Who Owns Immunic, Inc. (IMUX)?

According to the latest TipRanks data, approximately <0.01% of the company's stock is held by institutional investors, 9.28% is held by insiders, and 77.77% is held by retail investors.

What percentage of Immunic, Inc. (IMUX) stock is held by institutional investors?

According to the latest TipRanks data, approximately <0.01% of Immunic, Inc. (IMUX) stock is held by institutional investors.

What percentage of Immunic, Inc. (IMUX) stock is held by retail investors?

According to the latest TipRanks data, approximately 77.77% of Immunic, Inc. (IMUX) stock is held by retail investors.

Who owns the most shares of Immunic, Inc. (IMUX)?

Fidelity Concord Street Trust owns the most shares of Immunic, Inc. (IMUX).

What is the significance of the ownership structure for a publicly traded company?

The ownership structure can impact the company's decision making, as large institutional investors may exert influence on the company's management and can also affect the company's stock price with their buying and selling patterns.